EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Trends in Cases, Hospitalizations, and Mortality Related to the Omicron BA.4/BA.5 Subvariants in South Africa

Waasila Jassat, Salim S Abdool Karim, Lovelyn Ozougwu, Richard Welch, Caroline Mudara, Maureen Masha, Petro Rousseau, Milani Wolmarans, Anthony Selikow, Nevashan Govender, Sibongile Walaza, Anne von Gottberg und 8 weitere

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciac921 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Waasila Jassat und 19 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Johannesburg, South Africa. Hauptthemen laut MEDLINE: COVID-19, Laboratory Infection. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICD, NDoH, US Agency for International Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In this study, we compared admission incidence risk and the risk of mortality in the Omicron BA.4/BA.5 wave to previous waves.

Methods

Data from South Africa's SARS-CoV-2 case linelist, national COVID-19 hospital surveillance system, and Electronic Vaccine Data System were linked and analyzed. Wave periods were defined when the country passed a weekly incidence of 30 cases/100 000 population. In-hospital case fatality ratios (CFRs) during the Delta, Omicron BA.1/BA.2, and Omicron BA.4/BA.5 waves were compared using post-imputation random effect multivariable logistic regression models.

Results

The CFR was 25.9% (N = 37 538 of 144 778), 10.9% (N = 6123 of 56 384), and 8.2% (N = 1212 of 14 879) in the Delta, Omicron BA.1/BA.2, and Omicron BA.4/BA.5 waves, respectively. After adjusting for age, sex, race, comorbidities, health sector, and province, compared with the Omicron BA.4/BA.5 wave, patients had higher risk of mortality in the Omicron BA.1/BA.2 wave (adjusted odds ratio [aOR], 1.3; 95% confidence interval [CI]: 1.2–1.4) and Delta wave (aOR, 3.0; 95% CI: 2.8–3.2). Being partially vaccinated (aOR, 0.9; 95% CI: .9–.9), fully vaccinated (aOR, 0.6; 95% CI: .6–.7), and boosted (aOR, 0.4; 95% CI: .4–.5) and having prior laboratory-confirmed infection (aOR, 0.4; 95% CI: .3–.4) were associated with reduced risks of mortality.

Conclusions

Overall, admission incidence risk and in-hospital mortality, which had increased progressively in South Africa's first 3 waves, decreased in the fourth Omicron BA.1/BA.2 wave and declined even further in the fifth Omicron BA.4/BA.5 wave. Mortality risk was lower in those with natural infection and vaccination, declining further as the number of vaccine doses increased.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Laboratory InfectionHumansSouth AfricaSARS-CoV-2HospitalizationHospitals

Stichwörter der Autor:innen

COVID-19Omicron BA.4Omicron BA.5hospital admissionsmortality

Autor:innen und Institutionen

  • National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Johannesburg, South Africa.
  • Right to Care, Pretoria, South Africa.
  • Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
  • Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.
  • National Department of Health, Pretoria, South Africa.
  • Council for Scientific and Industrial Research, Pretoria, South Africa.

ORCID-Profile: Lucille Blumberg

Förderung

  • NICD
  • NDoH
  • US Agency for International Development

Zitieren

APA

Jassat, W., Abdool Karim, S. S., Ozougwu, L., Welch, R., Mudara, C., Masha, M., Rousseau, P., Wolmarans, M., Selikow, A., Govender, N., Walaza, S., von Gottberg, A., Wolter, N., Terrence Pisa, P., Sanne, I., Govender, S., Blumberg, L., Cohen, C., Groome, M. J., & DATCOV Author Group (2023). Trends in Cases, Hospitalizations, and Mortality Related to the Omicron BA.4/BA.5 Subvariants in South Africa. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac921

Vancouver

Jassat W, Abdool Karim SS, Ozougwu L, Welch R, Mudara C, Masha M, et al. Trends in Cases, Hospitalizations, and Mortality Related to the Omicron BA.4/BA.5 Subvariants in South Africa. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac921

BibTeX
@article{Jassat2023,
  author = {Jassat, Waasila and Abdool Karim, Salim S and Ozougwu, Lovelyn and Welch, Richard and Mudara, Caroline and Masha, Maureen and Rousseau, Petro and Wolmarans, Milani and Selikow, Anthony and Govender, Nevashan and Walaza, Sibongile and von Gottberg, Anne and Wolter, Nicole and Terrence Pisa, Pedro and Sanne, Ian and Govender, Sharlene and Blumberg, Lucille and Cohen, Cheryl and Groome, Michelle J and DATCOV Author Group, DATCOV Author Group},
  title = {Trends in Cases, Hospitalizations, and Mortality Related to the Omicron BA.4/BA.5 Subvariants in South Africa},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciac921}
}
Kostenlos starten →